Cargando…
QT interval and repolarization dispersion changes during the administration of hydroxychloroquine/chloroquine with/without azithromycin in early COVID 19 pandemic: A prospective observational study from two academic hospitals in Indonesia
BACKGROUND: Hydroxychloroquine/chloroquine (HCQ/CQ) treatment for COVID‐19 was associated with QT interval prolongation and arrhythmia risks. This study aimed to investigate QTc interval and ventricular repolarization dispersion changes, as markers of arrhythmia risks, after HCQ/CQ administration wi...
Autores principales: | Gumilang, Rizki A., Siswanto, Anggraeni, Vita Y., Trisnawati, Ika, Budiono, Eko, Hartopo, Anggoro B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485784/ https://www.ncbi.nlm.nih.gov/pubmed/34621417 http://dx.doi.org/10.1002/joa3.12623 |
Ejemplares similares
-
QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020) -
Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020) -
Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022) -
Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
por: Sarayani, Amir, et al.
Publicado: (2021) -
System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation
por: Khan, Abdul Arif, et al.
Publicado: (2020)